Font Size:
a
A
A
Keyword [BTK inhibitor]
Result: 1 - 20 | Page: 1 of 2
1.
Studies On The Clinical Significance Of BTK Expression And Synergistic Anti-tumor Effect Of BTK Inhibitor BGB-3111 Combinated With Bortezomib In Mantle Cell Lymphoma
2.
Effects And Mechanism Of Novel BTK Inhibitor AC0010 Treatment On Mantle Cell Lymphoma
3.
The Effect Of Abivertinib,A Novel BTK Inhibitor,and Its Mechanism Research In Acute Myeloid Leukemia
4.
The Role And The Significance Of BTK Regulates Ikaros In Acute Lymphoblastic Leukemia
5.
Study On Screening And Activity Evaluating Of BTK Or EGFR Inhibitors
6.
Design,Synthesis And Preliminary Activity Evaluation Of A New Type BTK Inhibitor
7.
Design,synthesis And Biological Evaluation Of BTK/HDAC Dual Target Inhibitors In Mantle Cell Lymphoma
8.
Stromal Cell Weakening And Salinomycin Enhance The Effect And Mechanism Of BTK Inhibitor Against MCL
9.
Therapeutic And Mechanic Studies Of An Artemisinin Derivative And A BTK Inhibitor In Autoimmune Diseases
10.
Structural Modification Based On Ibrutinib And Biologica Evaluation In Mantle Cell Lymphoma
11.
Study Of Effects Of HSP90 Inhibitor Ganetespib On The Sensitivity Of Mantle Cell Lymphoma To The BTK Inhibitor Ibrutinib And The Relevant Mechanisms
12.
Pharmacological Study Of Novel TRK Small Molecule Inhibitors And Strategies For Overcoming BTK Inhibitor Resistance
13.
Study On The Pharmacokinetics,Brain Tissue Distribution And Related Substance Methodology Of HBW-3-10 In Rats
14.
Ibrutinib Alleviates Sepsis-induced Acute Lung Injury Through Inhibiting NLRP3 Inflammasome-dependent Pyroptosis
15.
Disrupted Bone Marrow B-cell Microenviroments And Study Of Therapeutic Mechanisms Of BTK Inhibitor In ITP
16.
Design,Synthesis And Preliminary Biological Evaluation Of BTK/HDAC Dual Target Inhibitors
17.
Analysis Of The Safety And Effectiveness Of BTK Inhibitor In Treatment Of Chronic Lymphocytic Leukemia In The Real World
18.
Research On The Quality Standards Of APIs In The IND Application Stage Of A Targeted Anti-tumor Innovative Drug
19.
Efficacy And Prognosis Analysis Of BTK Inhibitor-containing Combination Chemotherapy Regimen On PCNSL
20.
Efficacy Of BTK Inhibitors In Treating Chronic Lymphocytic Leukemia And Their Effects On Cellular Immune Function
<<First
<Prev
Next>
Last>>
Jump to